Moore CB - Search Results

1

Multi-azole resistance in Aspergillus fumigatus.

Howard SJ, Webster I, Moore CB, Gardiner RE, Park S, Perlin DS, Denning DW. Howard SJ, et al. Among authors: moore cb. Int J Antimicrob Agents. 2006 Nov;28(5):450-3. doi: 10.1016/j.ijantimicag.2006.08.017. Epub 2006 Oct 10. Int J Antimicrob Agents. 2006. PMID: 17034993

2

Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009.

Bueid A, Howard SJ, Moore CB, Richardson MD, Harrison E, Bowyer P, Denning DW. Bueid A, et al. Among authors: moore cb. J Antimicrob Chemother. 2010 Oct;65(10):2116-8. doi: 10.1093/jac/dkq279. Epub 2010 Aug 20. J Antimicrob Chemother. 2010. PMID: 20729241

3

High-frequency triazole resistance found In nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease.

Denning DW, Park S, Lass-Florl C, Fraczek MG, Kirwan M, Gore R, Smith J, Bueid A, Moore CB, Bowyer P, Perlin DS. Denning DW, et al. Among authors: moore cb. Clin Infect Dis. 2011 May;52(9):1123-9. doi: 10.1093/cid/cir179. Clin Infect Dis. 2011. PMID: 21467016 Free PMC article.

4

The cdr1B efflux transporter is associated with non-cyp51a-mediated itraconazole resistance in Aspergillus fumigatus.

Fraczek MG, Bromley M, Buied A, Moore CB, Rajendran R, Rautemaa R, Ramage G, Denning DW, Bowyer P. Fraczek MG, et al. Among authors: moore cb. J Antimicrob Chemother. 2013 Jul;68(7):1486-96. doi: 10.1093/jac/dkt075. Epub 2013 Apr 10. J Antimicrob Chemother. 2013. PMID: 23580559

5

In vitro susceptibility of Aspergillus fumigatus to isavuconazole: correlation with itraconazole, voriconazole, and posaconazole.

Gregson L, Goodwin J, Johnson A, McEntee L, Moore CB, Richardson M, Hope WW, Howard SJ. Gregson L, et al. Among authors: moore cb. Antimicrob Agents Chemother. 2013 Nov;57(11):5778-80. doi: 10.1128/AAC.01141-13. Epub 2013 Sep 16. Antimicrob Agents Chemother. 2013. PMID: 24041890 Free PMC article.

6

Deciphering Aspergillus fumigatus cyp51A-mediated triazole resistance by pyrosequencing of respiratory specimens.

Novak-Frazer L, Anees-Hill SP, Hassan D, Masania R, Moore CB, Richardson MD, Denning DW, Rautemaa-Richardson R. Novak-Frazer L, et al. Among authors: moore cb. J Antimicrob Chemother. 2020 Dec 1;75(12):3501-3509. doi: 10.1093/jac/dkaa357. J Antimicrob Chemother. 2020. PMID: 32862231 Free PMC article.

7

In-vitro activity of the new triazole D0870 compared with amphotericin B and itraconazole against Aspergillus spp.

Moore CB, Law D, Denning DW. Moore CB, et al. J Antimicrob Chemother. 1993 Dec;32(6):831-6. doi: 10.1093/jac/32.6.831. J Antimicrob Chemother. 1993. PMID: 8144422

8

In vitro activity of SCH-56592 and comparison with activities of amphotericin B and itraconazole against Aspergillus spp.

Oakley KL, Moore CB, Denning DW. Oakley KL, et al. Among authors: moore cb. Antimicrob Agents Chemother. 1997 May;41(5):1124-6. doi: 10.1128/AAC.41.5.1124. Antimicrob Agents Chemother. 1997. PMID: 9145880 Free PMC article.

9

In-vitro activity of voriconazole against Aspergillus spp. and comparison with itraconazole and amphotericin B.

Oakley KL, Moore CB, Denning DW. Oakley KL, et al. Among authors: moore cb. J Antimicrob Chemother. 1998 Jul;42(1):91-4. doi: 10.1093/jac/42.1.91. J Antimicrob Chemother. 1998. PMID: 9700534

10

In vitro activity of the echinocandin antifungal agent LY303,366 in comparison with itraconazole and amphotericin B against Aspergillus spp.

Oakley KL, Moore CB, Denning DW. Oakley KL, et al. Among authors: moore cb. Antimicrob Agents Chemother. 1998 Oct;42(10):2726-30. doi: 10.1128/AAC.42.10.2726. Antimicrob Agents Chemother. 1998. PMID: 9756785 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

259 results

Search Page